PRISM MediaWire

Lipella Pharmaceuticals to Progress Development of Oral Graft-versus-Host-Disease Treatment Candidate

New York, March 06, 2024 - PRISM MediaWire - "Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) secures FDA Approval for Investigational New Drug (IND) Application, Advancing Clinical Testing of LP-410 for Oral Graft-Versus-Host Disease (GvHD) Treatment. Clinical Study Set to ...

6 March 2024

SKYX Enters Collaboration with Golden Lighting to Introduce Smart Plug & Play Products into Expanded Sales Channels

New York, March 06, 2024 - PRISM MediaWire - SKYX Platforms Corp. (Nasdaq: SKYX) announces a strategic partnership with Golden Lighting, a renowned manufacturer and premier provider of elegant lighting solutions. This collaboration aims to facilitate SKYX's introduction ...

6 March 2024

IceCure's ProSense® Achieves Complete Tumor Reduction in Early-Stage Breast Cancer

New York, March 06, 2024 - PRISM MediaWire - IceCure Medical Ltd. (Nasdaq: ICCM) has disclosed novel findings from an initial, autonomous breast cancer investigation, revealing a median tumor reduction of 100% at both six and twelve months subsequent to cryoablation in w...

6 March 2024

Sports Gear and Apparel

DRYWORLD Brands (IBGR) Strategically Positions Itself for Game-Changing Impact in 2024 Following Dynamic Moves in 2023

New York, March 05, 2024 - PRISM MediaWire - Today, DRYWORLD Brands, Inc. ($IBGR), a leading global sports brand renowned for premium performance, delivered its annual corporate update to the investment community. The update showcased remarkable achievements, including a...

5 March 2024

Topline Data Anticipated for Suicidal Bipolar Depression Treatment Trial by NRx

New York, March 05, 2024 - PRISM MediaWire - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) achieves 'Last Patient, Last Visit' milestone in Phase 2b/3 Trial of NRX-101 for suicidal treatment-resistant bipolar depression. The company confirms completion of the 74th and final e...

5 March 2024

Quoin Pharmaceuticals Expands Rare Disease Clinical Trials to Encompass Teen Patients

New York, March 04, 2024 - PRISM MediaWire - Clinical-stage biotechnology firm Quoin Pharmaceuticals (Nasdaq: QNRX) has obtained FDA clearance to enroll subjects aged 14 years and above into its two ongoing clinical trials for QRX003. These trials are dedicated to assess...

4 March 2024

Artificial Intelligence:

Advancements in Artificial Intelligence Enhance Travel Experience in 2024: TSA Precheck and Airlines Introduce "Touchless ID" System; BBAI Stock Surges Approximately 30% Following Announcement of "Vision AI" Acquisition

New York, March 04, 2024 - PRISM MediaWire - United Airlines (UA) is set to introduce "Touchless ID" technology, replacing traditional boarding passes and IDs for passengers traveling through Chicago O'Hare and Los Angeles International airports. The program is slated fo...

4 March 2024

Vocodia Announces Phase One of Service Platform Installation at Dealers of One of Big 3 Automobile Resellers

Installation at 1,800 Dealerships in Total Expected, including 1,000 in Year 1

26 February 2024

Artificial Intelligence:

Ethical Web AI Launches AI Seek 6.0

Generative AI app, Seek AI is now market-ready and has an extended free access period

23 January 2024

Bubblr, Inc., d/b/a Ethical Web AI Strengthens 2023 Year-End Balance Sheet

NEW YORK, January 08, 2024 - PRISM MediaWire - Bubblr Inc., d/b/a Ethical Web AI. (OTCQB: BBLR), a frontrunner in ethical technology determined to revolutionize the digital domain, today announced that it has strengthened the balance sheet of the Company through two acti...

8 January 2024